Sichuan Huiyu Pharmaceutical Co. Ltd. (688553)

Overview

Sichuan Huiyu Pharmaceutical Co., Ltd. is a distinguished pharmaceutical company that focuses on the research, development, production, and sales of anti-tumor and injection drugs. Having expanded its market reach both domestically within China and internationally, the company has established a significant presence in the pharmaceutical industry since its incorporation in 2010. Headquartered in Neijiang, China, Sichuan Huiyu Pharmaceutical leverages advanced technological capabilities and rigorous research methodologies to bring innovative and effective healthcare solutions to patients around the world.

Products and Services

The company boasts a comprehensive portfolio of injection drug products targeting a variety of conditions, primarily focusing on oncology, but also addressing other medical needs. Each product is developed with the aim of improving patient outcomes and offering healthcare professionals effective tools in the management and treatment of diseases. Below is an overview of their main products:

• Pemetrexed Disodium: An antifolate chemotherapy drug used primarily in the treatment of pleural mesothelioma and non-small cell lung cancer.
• Methrotraxate: A chemotherapy agent and immune system suppressant, often used to treat cancer, autoimmune diseases, and ectopic pregnancy.
• Docetaxel: A chemotherapy medication used in the treatment of various cancers, including breast, lung, prostate, and stomach cancers.
• Azacitidine: A chemical compound used mainly for the treatment of myelodysplastic syndrome, a group of cancers where immature blood cells do not develop properly.
• Oxaliplatin: A platinum-based chemotherapy drug used to treat colorectal cancer.
• Irinotecan Hydrochloride: Primarily used in the treatment of colon cancer, it works by interfering with the DNA replication of cancer cells.
• Paclitaxel: A chemotherapy drug used to treat a number of cancers including ovarian, breast, lung, pancreatic, and cervical cancers.
• Bendamustine Hydrochloride: Used mainly for treating chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
• Palonosetron Hydrochloride: A medication for preventing chemotherapy-induced nausea and vomiting.
• Plerixafor: An immunostimulant used to mobilize stem cells in cancer patients before treatment.
• Levetiracetam Concentrated Solution: An anticonvulsant used to treat epilepsy.
• Sodium Valproate Concentrated Solution: Used to treat epilepsy and bipolar disorder, and to prevent migraine headaches.
• Epirubicin Hydrochloride: A chemotherapy drug used in the treatment of breast cancer.
• Fulvestrant: An estrogen receptor antagonist used in the treatment of hormone receptor-positive metastatic breast cancer.
• Milrinone: A medication used in the treatment of heart failure.
• Fluorouracil: A medication used to treat cancer.
• Sodium Thiosulfate: Used in conjunction with chemotherapy as a cytoprotectant.
• Zoledronic Acid and its Concentrated Solution: Used to treat bone diseases that occur with cancer.
• Cisatracurium Besylate: A muscle relaxant used during surgery or mechanical ventilation.
• Bortezomib: A medication used to treat multiple myeloma and mantle cell lymphoma.
• Octreotide Acetate: Used for the treatment of growth hormone-producing tumors and certain disorders associated with carcinoid tumors and vasoactive intestinal peptide secreting tumors (VIPomas).
• Doxorubicin: A chemotherapy drug used to treat various types of cancer.
• Palonosetron Hydrochloride (repeated listing is consolidated here with its initial mention for preventing chemotherapy-induced nausea and vomiting).